Comparing Suture vs. Combined Closure Strategies for Large Blood Vessel Access in Patients Undergoing Transcatheter Aortic Valve Implantation (TAVI)
A legfontosabb adatok
- Ki végzi
- University Hospital, Basel, Switzerland
- Hol
- Basel (Svájc)A helyszín megnézése
- Azonosító
- Állapot
- Toborzás még nem indult
- Résztvevők
- 705 fő, tervezett
- Kezdés
- 2026. okt. 1.
- Várható befejezés
- 2028. szept.
- A vizsgálat típusa
- Beavatkozással járó, 2 csoportAz egyik csoport egy már használt kezelést kap, összehasonlításként.
- A vizsgált kezelések
- Single Suture-Based Vascular Closure Device
- Extravascular Collagen Plug-Based Closure Device
- A regiszteradat frissítve
- 2026. augusztus 4.
Ki vehet részt
MI-összefoglaló
A vizsgálat saját részvételi feltételeiből. Gép olvasta ki az oldalon álló regiszterszövegből, ezért tévedhet. Hogy ki vehet részt, azt a lenti regiszterszöveg és a vizsgálat csapata dönti el.
The trial is looking for adults with a planned TAVI (a heart valve replacement done through a tube) through the main artery in the leg. It compares two ways to close the artery afterwards.
- Életkor
- 18 years or older.
- Nem
- All sexes can join.
- A betegség stádiuma
- People with a planned, non-emergency TAVI through the leg artery. The local Heart Team must judge they can have this procedure and the large artery closure.
A részvétel fő kizáró okai
- TAVI planned through another route than the leg artery, or an emergency TAVI.
- Leg artery size, calcium build-up or twisting that does not allow the standard closure devices.
- Active infection at the planned access site, or severe allergy to bovine tissue, collagen or parts of Perclose ProGlide/ProStyle or Angio-Seal.
- Severe bleeding problems, active major bleeding, or unable to take blood thinners or antiplatelet drugs.
- Pregnant or breastfeeding, or taking part in another device or drug trial.
A regiszter feltételei, szó szerint
Mind a 14 feltétel megnézéseKevesebb
Ki vehet részt
- Patient is at least 18 years of age at the time of screening
- Patient is scheduled to undergo elective transcatheter aortic valve implantation (TAVI) via transfemoral arterial access
- Patient is deemed suitable for transfemoral TAVI and large-bore vascular access closure by the local Heart Team
- Patient (or legally authorized representative) provides written informed consent prior to initiating any study-related procedures
- Patient is willing and able to comply with all specified study procedures, follow-up visits, and clinical evaluations
Ki nem vehet részt
- Concurrent participation in another interventional clinical trial investigating cardiovascular devices or drugs that could confound study endpoints
- Known active, unresolved local or systemic infection at the planned vascular access site
- Known severe allergy or hypersensitivity to bovine tissue, collagen, or any component of the study closure devices (Perclose ProGlide/ProStyle or Angio-Seal) that cannot be adequately premedicated
- Severe bleeding diathesis, active major bleeding, or absolute contraindication to standard periprocedural anticoagulation or antiplatelet therapy
- Planned TAVI procedure via non-femoral arterial access (e.g., transapical, transaortic, subclavian/axillary, or carotid access)
- Emergency or non-elective TAVI procedure
- Target main femoral artery vessel diameter, calcification, or tortuosity judged unsuitable for standard percutaneous large-bore vascular closure device deployment
- Patient is pregnant or breastfeeding
- Patient belongs to a vulnerable population (e.g., individuals deprived of liberty, under guardianship, or unable to give informed consent)
Helyszínek itt: Svájc
- University Heart Center Basel, University Hospital BaselBasel, SvájcContact: Max Wagener, MD, MScToborzás még nem indult
A vizsgálatról
Mit akar kideríteni a vizsgálat
The goal of this clinical trial is to compare two strategies for closing the main artery access site in adult patients undergoing transcatheter aortic valve implantation (TAVI) through a blood vessel in the leg (transfemoral access).
A teljes eredeti leírásKevesebb
The main questions it aims to answer are:
Does using a single suture device lower the rate of access-related vascular complications compared to using a hybrid combination of a suture device and a plug-based closure device? How do the two closure strategies compare regarding bleeding complications, procedure time, and time to complete vessel sealing?
Researchers will compare a single-suture closure strategy to a hybrid closure strategy (one suture plus one plug-based device) to see if using a single suture reduces vessel-related complications and improves patient safety after TAVI.
Participants will:
Undergo standard pre-procedure screening and TAVI via the main artery in the leg as part of routine medical care.
Receive an initial single-suture placement before the large TAVI delivery system is inserted.
Be evaluated after sheath removal for initial bleeding control; qualifying participants will then be randomly assigned (1:1) to either receive no additional device (single suture group) or receive a plug-based closure device (hybrid group).
Have their heart and access site monitored during hospitalization, including laboratory checks and imaging prior to discharge.
Complete a 72-hour safety and complication evaluation.
A vizsgálat 2 csoportja
- Single-Suture StrategyMár használt kezelés, összehasonlításként
Single suture-based vascular closure device (VCD) pre-placed prior to sheath insertion.
Kezelés: Single Suture-Based Vascular Closure Device
- Hybrid Strategy (Suture + Plug)A vizsgált kezelés
Single suture-based VCD combined with an extravascular plug-based VCD (Angio-Seal®)
Kezelés: Extravascular Collagen Plug-Based Closure Device
Kérdések a vizsgálat csapatának
- Milyen gyakran kell bejárnom, és egy-egy alkalom mennyi ideig tart?
- Megtérítik az utazási költséget?
- Megtarthatom a saját orvosomat?
- Mi történik, ha ki akarok lépni?
Contact the study team: see the registry record → Contacts and Locations
Oldal nyomtatása az orvosomnakAdatok és források
- Regiszteradat
- Szerepel a ClinicalTrials.gov-on.
- Hivatalos cím
- SEAL-TAVI - Suture vs combinEd Closure strAtegies in Large-bore Access After TAVI
- MI-összefoglaló
- A vizsgálat saját részvételi feltételeiből. Gépi kiolvasás: 2026. november 14.
- A regiszteradat frissítve
- 2026. augusztus 4.